Effects of Miramistin and Phosprenil on Microbial Biofilms

Area of Science:

• Microbiology
• Antimicrobial Research
• Biofilm Formation

Background:

• Microbial biofilms pose significant challenges in healthcare and industry.
• Understanding the efficacy of antimicrobial agents against biofilms is crucial.
• Specific agents like Miramistin and Phosprenil have shown potential in combating microbial growth.

Purpose of the Study:

• To investigate the effects of Miramistin and Phosprenil on the formation and established biofilms of key microorganisms.
• To compare the efficacy of these agents at different concentrations and stages of biofilm development.
• To determine the dose-dependent responses of various bacterial species to Miramistin and Phosprenil.

Main Methods:

• Studying the impact of Miramistin and Phosprenil on biofilms of *S. pyogenes*, *S. aureus*, *E. coli*, *L. acidophilus*, and *L. plantarum*.
• Evaluating the agents' effects on both biofilm formation and mature biofilms.
• Assessing dose-dependent inhibition and stimulation of biofilm growth.

Main Results:

• Miramistin demonstrated significant inhibition of biofilm formation (2-3 times reduction) and mature biofilms (at higher doses) across all tested microorganisms.
• Phosprenil effectively inhibited biofilm formation, particularly for *S. pyogenes* and *L. plantarum* (3-4.5 times reduction) at high doses.
• Low doses of Phosprenil (0.6-6.0 mg/ml) paradoxically stimulated the growth of mature biofilms in *S. pyogenes*, *S. aureus*, and *L. acidophilus*.

Conclusions:

• Miramistin is a potent inhibitor of both biofilm formation and established biofilms for a range of microorganisms.
• Phosprenil's effect on biofilms is concentration-dependent, with high doses inhibiting formation but lower doses potentially promoting growth.
• These findings highlight the differential activity of antimicrobial agents and underscore the importance of dose selection in biofilm management.